{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1200"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"}],"units":"Participants"}],"description":"Atezolizumab was administered on Day 1 only for a cycle duration of 3 weeks.","groups":[{"description":"Participants \\>=18 Age (Years)","id":"OG000","title":">=18 Age (Years)"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"From baseline up to approximately 42 months","title":"Optimal Dose of Atezolizumab in Young Adult Participants","type":"SECONDARY","unitOfMeasure":"mg"}